Active substances
Docusate + Sennosides
- SFDA 2
- Health Canada 5
- US price lines 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LAXATROL 50 MG/8.60 MG FILM COATED TABLET (100S) | 50,8.6 mg,mg | Film-coated tablet · Oral use | 100 Bottle | SAR 42.90 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| LAXATROL 50 MG/8.60 MG FILM COATED TABLET (30S) | 50 , 8 mg | Film-coated tablet · Oral use | 30 Blister | SAR 13.50 | NCE · Prescription | Jamjoom Pharmaceuticals Factory Company | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ADULT ACUTE LYMPHOCYTIC LEUKEMIA (ALL)-ADVERSE REACTIONS MANAGEMENT; ANAL FISSURE; CONSTIPATION; HEMORRHOIDS; PEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL)-ADVERSE REACTIONS MANAGEMENT
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| COLACE PLUS STIMULANT LAXATIVE | 02516209 | 50 MG; 8.6 MG | TABLET · ORAL | PHARMASCIENCE INC |
| SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS | 02247134 | 50 MG; 8.6 MG | TABLET · ORAL | VITA HEALTH PRODUCTS INC |
| SENNA S. TABLETS | 02246951 | 8.6 MG; 50 MG | TABLET · ORAL | SIGMA LIFE SCIENCES INC. |
| SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG TABLETS | 02553007 | 8.6 MG; 50 MG | TABLET · ORAL | TIME-CAP LABORATORIES, INC |
| SENOKOT S | 00026123 | 8.6 MG; 50 MG | TABLET · ORAL | INOVA PHARMACEUTICALS (AUSTRALIA) PTY LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | SENNOSIDES-DOCUSATE SODIUM TAB | $0.02971 | per EA | 23 Sep 2026 |
| US NADAC | SENOKOT-S TABLET | $0.41197 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.